Back to top

VRDN: Needham Maintains Buy Rating, Lowers Price Target to $34.00 | VRDN Stock News

VRDN: Needham Maintains Buy Rating, Lowers Price Target to $34.00 | VRDN Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Viridian Therapeutics, Inc. (VRDN)